FDA
Is your medicine cabinet full of expired drugs or medications you no longer use? The best way to dispose of most types of expired, unwanted or unused medicines is through a drug take-back program. To discard of your prescription or over-the-counter medicines, you can: If you cannot use those options,
FDA
Little teapots with long spouts have become a fixture in many homes to flush out clogged nasal passages and help people breathe easier. Along with other nasal irrigation devices, these devices — commonly called neti pots — use a saline, or saltwater, solution to treat congested sinuses, colds and allergies. They’re
FDA
The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult
FDA
For Immediate Release: September 09, 2025The U.S. Department of Health and Human Services and the Food and Drug Administration today announced sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements. Today, the FDA is sending thousands of letters warning pharmaceutical companies to remove misleading ads and issuing approximately 100
FDA
Nicotine pouches can be dangerous to children if they use, touch, chew on, or eat them. These small fiber pouches, which contain nicotine that is chemically synthesized or derived from the tobacco leaf, can cause nicotine poisoning in children. It’s important to keep these products away from kids and
FDA
For Immediate Release: September 03, 2025The U.S. Food and Drug Administration today introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven
FDA
For Immediate Release: September 10, 2025Despite recent declines, opioids remain commonly prescribed to about 1 in 5 U.S. adults who live with chronic pain as effective alternatives are limited. As part of its broader strategy to address the opioid crisis, the U.S. Food and Drug Administration today issued
FDA
For Immediate Release: September 05, 2025The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market. This is part of the agency’s decisive steps
FDA
We can help stop the spread of COVID-19 and other infectious diseases by washing our hands regularly with soap and water for 20 seconds – especially after going to the bathroom, before eating, and after coughing, sneezing, or blowing our nose. If soap and water are not available, the Centers for
FDA
For Immediate Release: August 14, 2025Today, the U.S. Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba), a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent respiratory papillomatosis (RRP). RRP is a rare, chronic disease caused by persistent human papillomavirus (HPV) 6 or 11 infection,
FDA
The U.S. Food and Drug Administration is responsible for protecting the public health by, among other things, ensuring the safety and effectiveness of drugs, biological products and medical devices. In certain circumstances, the FDA allows the emergency use of medical products that do not yet have agency approval. The
FDA
For Immediate Release: June 27, 2025The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies. These products are gene therapies that are currently approved to treat